In their December 2016 Editor's Choice article, entitled "Human T Lymphocytes Bioactivate Heterocyclic Aromatic Amines by Forming DNA Adducts," Bellamri et al. report important new information that will inform the public about cancer risk associated with heterocyclic aromatic amines.
The October 2016 Editor's choice article is "Transcriptional benchmark dose modeling: Exploring how advances in chemical risk assessment may be applied to the radiation field" by Vinita Chauhan, Byron Kuo, James P. McNamee, Ruth C. Wilkins and Carole L. Yauk.
